Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation. (2014)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/clpt.2013.190
PubMed Identifier: 24067746
Publication URI: http://europepmc.org/abstract/MED/24067746
Type: Journal Article/Review
Volume: 95
Parent Publication: Clinical pharmacology and therapeutics
Issue: 2
ISSN: 0009-9236